Status:
RECRUITING
Mitral Valve Screening Survey
Lead Sponsor:
Medstar Health Research Institute
Conditions:
Mitral Valve Disease
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to examine the clinical profile/anatomical characteristics and natural history of patients who subsequently fail screening for transcatheter mitral valve intervention (TMVI).
Detailed Description
Numerous transcatheter mitral valve interventions have emerged as a treatment option for patients with mitral valve disease. Development of transcatheter mitral valve repair (TMVr) and transcatheter m...
Eligibility Criteria
Inclusion
- Subject failed screening for TMVI
Exclusion
- Under 18 years of age
- Subject unable or unwilling to give informed consent
- Subject proceeded with TMVI.
Key Trial Info
Start Date :
August 6 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2027
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04736667
Start Date
August 6 2021
End Date
February 1 2027
Last Update
August 29 2025
Active Locations (16)
Enter a location and click search to find clinical trials sorted by distance.
1
Phoenix Cardiovascular Research Group
Phoenix, Arizona, United States, 85016
2
Keck Hospital of USC
Los Angeles, California, United States, 90033
3
MedStar Washington Hospital Center
Washington D.C., District of Columbia, United States, 20010
4
Morton Plant Hospital
Clearwater, Florida, United States, 33756